Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 6 EP applications Caroline Romanowski has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11761652

BIOTINYLATED POLYSACCHARIDES HAVING AN ANTITHROMBOTIC ACTIVITY AND IMPROVED METABOLIC STABILITY

IPC classification:
A61K 31/727, C08B 37/08
Agent:
Caroline Romanowski, Sanofi
Status:
GRANT OF PATENT INTENDED
EP12718395

POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS

IPC classification:
A61K 31/727, C08B 37/00
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
EXAMINATION REQUESTED
EP12719984

SEMULOPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS RECEIVING CHEMOTHERAPY

IPC classification:
A61K 31/727, A61K 31/00, A61P 35/00, A61P 7/02
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi
Agent:
Caroline Romanowski, Sanofi, S.A.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13305130

Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients

IPC classification:
A61K 31/505, A61K 31/277, A61P 25/00
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION REFUSED
EP12702546

IDRABIOTAPARINUX FOR THE TREATMENT OF PULMONARY EMBOLISM AND FOR THE SECONDARY PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS

IPC classification:
A61P 7/02, A61K 31/715, A61K 31/7056
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14761286

PYRAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF BLADDER CANCER

IPC classification:
A61P 35/00, A61K 31/444, A61K 31/4545, A61K 31/437
Applicant:
Sanofi, S.A.
Agent:
Cabinet Nony
Agent:
Caroline Romanowski, Sanofi
Status:
The patent has been granted

Please Sign in to use this feature